Disrupting Notch signaling related HES1 in myeloid cells reinvigorates antitumor T cell responses
Open Access
- 19 December 2024
- journal article
- research article
- Published by Springer Nature in Experimental Hematology & Oncology
- Vol. 13 (1) , 1-19
Abstract
Background: Tumor-associated macrophages (TAMs) are immunosuppressive cells within the tumor microenvironment (TME) that hinder anti-tumor immunity. Notch signaling is a pathway crucial for TAM differentiation and function. Here, we investigate the role of HES1, a downstream target of Notch signaling, in TAM-mediated immunosuppression and explore its potential as a target for cancer immunotherapy. Methods: In this work, we constructed conditional Hes1 knockout mice to selectively delete Hes1 in TAMs. We further analyzed the TME composition, T cell infiltration and activation, and anti-tumor effects in these mice, both alone and in combination with PD-1 checkpoint blockade. Results: Our study showed that expression levels of Notch target Hes1 were increase in TAMs and mice with conditional knockout of Hes1 gene in TAMs exhibited decreased tumor growth, with increased infiltration and activation of cytotoxic T cells in tumors. Expression of tumor promoting factors was critically altered in Hes1-conditional KO TAMs, leading to the improved tumor microenvironment. Notably, arginase-1 expression was decreased in Hes1-conditional KO mice. Arg1 is known to deplete arginine and deactivate T cells in the TME. Administration of anti-PD-1 monoclonal antibody inhibited tumor growth to a greater extent in Hes1-conditional KO mice than in WT mice. Conclusions: We identified a pivotal role for the Notch signaling pathway in shaping TAM function, suggesting that T-cell dysfunction in the TME is caused when the Notch target, HES1, in TAMs is upregulated by tumor-associated factors (TAFs), which, in turn, increases the expression of arginase-1. Targeting HES1 in TAMs appears to be a promising strategy for cancer immunotherapy.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (NRF-2019R1A2C208923712, NRF-2022R1A2C200730012, RS-2023-00285353, NRF-2019R1A2C208923712)
- Yonsei University College of Medicine (6-2021-0080)
This publication has 102 references indexed in Scilit:
- The role of tumor-associated macrophages in tumor immune evasionJournal of Cancer Research and Clinical Oncology, 2024
- Macrophages M2 polarization is involved in lapatinib-mediated chemopreventive effects in the lung cancerBiomedicine & Pharmacotherapy, 2023
- The emerging role of PPAR-alpha in breast cancerBiomedicine & Pharmacotherapy, 2023
- Hypoxia promotes conversion to a stem cell phenotype in prostate cancer cells by activating HIF-1α/Notch1 signaling pathwayClinical and Translational Oncology, 2023
- MO10-6 Phase 1 study of retifanlimab (anti-PD-1) and INCB001158 (arginase inhibitor), alone or in combination, in solid tumorsAnnals of Oncology, 2021
- Hes1deficiency causes hematopoietic stem cell exhaustionStem Cells, 2020
- Landscape and Dynamics of Single Immune Cells in Hepatocellular CarcinomaCell, 2019
- C/EBPβ regulates the M2 transcriptome in β-adrenergic-stimulated macrophagesBrain, Behavior, and Immunity, 2019
- Tumors and Their Microenvironment Dual‐Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast CancerAdvanced Science, 2019
- TGF‐α induces upregulation and nuclear translocation of Hes1 in glioma cellCell Biochemistry and Function, 2008